Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan
Human Psychopharmacology: Clinical and Experimental · 2024
DOI: 10.1002/hup.2890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2024. Verfasst von Keisuke Aoyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu-shi, Gifu, Japan. Hauptthemen laut MEDLINE: Polypharmacy, Psychotropic Drugs, Mental Disorders, Inpatients. Die Arbeit nennt 52 Literaturangaben.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Objective
In psychiatry, polypharmacy or high psychotropic drug doses increase adverse drug event (ADE) prevalence. However, the full relationship between polypharmacy and ADEs is unclear, and few studies have evaluated dose equivalents for psychotropic drugs for ADEs. Thus, we conducted a retrospective analysis to clarify the effects of polypharmacy and chlorpromazine (CP)‐, diazepam (DAP)‐, and imipramine‐ equivalent doses on all ADEs in inpatients.
Methods
Psychiatric inpatients in a Japanese hospital from April 1, 2016 to March 31, 2018, were enrolled. ADE severity and causality were assessed. Multiple logistic regression analyses were performed to evaluate ADE risk factors.
Results
Among 462 patients analyzed, out of 471 patients enrolled, 145 (31.4%) experienced ADEs. The causality assessment determined that “possible” was 96.5%. The most common ADEs were nervous system disorders (35%). Multiple logistic regression analyses indicated an increase in ADE prevalence with the number of drugs used (≥5; p = 0.026); CP‐equivalent dose ( p = 0.048); and endocrine, nutritional, and metabolic disorders ( p = 0.045). DAP‐equivalent dose; infectious and parasitic diseases; and injury, poisoning, and consequences of other external causes decreased ADE prevalence ( p = 0.047, 0.022, and 0.021, respectively).
Conclusions
Avoiding polypharmacy in psychiatric inpatients and adjusting drug regimens to safe equivalent doses could reduce ADEs during hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu-shi, Gifu, Japan.
- Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya-shi, Aichi, Japan.
- Laboratory of Pharmaceutical Health Care and Promotion, Gifu Pharmaceutical University, Gifu-shi, Gifu, Japan.
- Department of Pharmacy, Gifu Municipal Hospital, Gifu-shi, Gifu, Japan.
- Department of Psychiatry, Gifu Municipal Hospital, Gifu-shi, Gifu, Japan.
ORCID-Profile: Tomoya Tachi
Zitieren
APA
Aoyama, K., Tachi, T., Kubo, S., Koyama, A., Watanabe, M., Aoyama, S., Noguchi, Y., Tanaka, K., Yasuda, M., Shibata, A., Mizui, T., & Teramachi, H. (2024). Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2890
Vancouver
Aoyama K, Tachi T, Kubo S, Koyama A, Watanabe M, Aoyama S, et al. Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan. Human Psychopharmacology: Clinical and Experimental. 2024. doi:10.1002/hup.2890
BibTeX
@article{Aoyama2024,
author = {Aoyama, Keisuke and Tachi, Tomoya and Kubo, Satoaki and Koyama, Aisa and Watanabe, Mayuko and Aoyama, Satoshi and Noguchi, Yoshihiro and Tanaka, Kazuhide and Yasuda, Masahiro and Shibata, Akihiko and Mizui, Takashi and Teramachi, Hitomi},
title = {Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2024},
doi = {10.1002/hup.2890}
}
EUVIMED